The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule V if it finds that:
(1) the substance has low potential for misuse relative to the controlled substances listed in Schedule IV;(2) the substance has currently accepted medical use in treatment in the United States; and(3) misuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule IV, or the substance is a targeted methamphetamine precursor as defined in the Methamphetamine Precursor Control Act.Amended by P.A. 103-0881,§ 20, eff. 1/1/2025.Amended by P.A. 097-0334,§ 5, eff. 1/1/2012.Amended by P.A. 094-0694, § 900, eff. 1/15/2006.